Restylane Shaype Versus Juvederm Volux for Chin Augmentation (NCT06336772) | Clinical Trial Compass
CompletedNot Applicable
Restylane Shaype Versus Juvederm Volux for Chin Augmentation
Canada40 participantsStarted 2023-10-23
Plain-language summary
This study aims to compare two injectable products (Restylane Shaype and Juvéderm Volux) for aesthetic augmentation of the chin
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. At the time of consent, male and female subjects 18 years of age and older.
. Patients with established chin retrusion at Baseline (a score of mild, moderate, and severe severity on the Galderma Chin Retrusion Scale).
. Accepted the obligation not to receive any other facial procedures throughout the study duration.
. Understood and accepted the obligation and would be logistically able to appear for all scheduled follow-up visits.
. No previous lower face fillers for 12 months prior to this study.
. Capable of providing informed consent.
Exclusion criteria
. Patients without chin retrusion at Baseline, per the Galderma Chin Retrusion Scale.
. Current Pregnancy or lactation \[sexually active women of childbearing age must agree to use medically acceptable methods of contraception for the duration of this study (e.g., oral contraceptives, condoms, intrauterine device, shot/injection, patch)\].
. Hypersensitivity to Restylane or Juvéderm products, hyaluronic acid filler or amide local anesthetics.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Statistically significant group differences in the average three-dimensional volumetric increase since baseline
. Patients presenting with porphyria or any other liver diseases.
. Inability to comply with follow-up and abstain from facial injections during the study period.
. Heavy smokers, classified as smoking more than 12 cigarettes per day.
. History of severe or multiple allergies manifested by anaphylaxis since drug allergies might preclude optimal management of complications.
. Previous tissue revitalization therapy in the treatment area (i.e., the lower face) within 6 months before treatment with laser or light, mesotherapy, radiofrequency, ultrasound, cryotherapy, chemical peeling, or dermabrasion.